tradingkey.logo

Kamada Ltd

KMDA

7.220USD

0.000
Market hours ETQuotes delayed by 15 min
415.19MMarket Cap
25.85P/E TTM

Kamada Ltd

7.220

0.000
More Details of Kamada Ltd Company
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Company Info
Ticker SymbolKMDA
Company nameKamada Ltd
IPO dateAug 01, 2005
CEOMr. Amir London
Number of employees374
Security typeOrdinary Share
Fiscal year-endAug 01
Address2 Holtzman St., Science Park
CityREHOVOT
Stock exchangeNASDAQ Global Select Consolidated
CountryIsrael
Postal code7670402
Phone97289406472
Websitehttps://www.kamada.com/
Ticker SymbolKMDA
IPO dateAug 01, 2005
CEOMr. Amir London
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
+3.12%
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Mr. Barak Bashari
Mr. Barak Bashari
Vice President - Operations
Vice President - Operations
--
--
Dr. Michal Stein
Dr. Michal Stein
Vice President and Medical Director for Immunology
Vice President and Medical Director for Immunology
--
--
DR. Michal Ayalon
DR. Michal Ayalon
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
--
--
Dr. Estery Giloz-Ran
Dr. Estery Giloz-Ran
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
+3.12%
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Mr. Barak Bashari
Mr. Barak Bashari
Vice President - Operations
Vice President - Operations
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
U.S.A
30.16M
68.51%
Israel
5.35M
12.16%
Latin America
4.61M
10.48%
Canada
3.04M
6.90%
Asia
790.00K
1.79%
Europe
70.00K
0.16%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
First Israel Mezzanine Investors Ltd.
38.40%
Gov Financial Holdings, Ltd.
4.87%
Phoenix Investment and Finances Ltd
2.88%
Renaissance Technologies LLC
1.41%
Recanati (Leon Yehuda)
1.10%
Other
51.34%
Shareholders
Shareholders
Proportion
First Israel Mezzanine Investors Ltd.
38.40%
Gov Financial Holdings, Ltd.
4.87%
Phoenix Investment and Finances Ltd
2.88%
Renaissance Technologies LLC
1.41%
Recanati (Leon Yehuda)
1.10%
Other
51.34%
Shareholder Types
Shareholders
Proportion
Private Equity
38.40%
Corporation
4.87%
Investment Advisor
4.01%
Hedge Fund
2.51%
Individual Investor
2.34%
Investment Advisor/Hedge Fund
2.14%
Research Firm
1.63%
Other
44.08%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
80
32.16M
55.93%
-1.18M
2025Q1
80
31.87M
55.42%
-1.29M
2024Q4
72
32.96M
57.32%
-768.38K
2024Q3
87
33.30M
57.92%
-790.28K
2024Q2
91
33.17M
57.70%
-784.97K
2024Q1
93
32.46M
56.47%
-1.61M
2023Q4
102
32.56M
56.63%
-1.63M
2023Q3
106
34.53M
63.12%
+10.56M
2023Q2
108
21.99M
49.05%
-2.19M
2023Q1
111
22.14M
49.40%
-1.73M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
First Israel Mezzanine Investors Ltd.
22.08M
38.4%
--
--
Dec 31, 2024
Gov Financial Holdings, Ltd.
2.80M
4.87%
-55.95K
-1.96%
Dec 31, 2024
Phoenix Investment and Finances Ltd
1.65M
2.88%
-178.00K
-9.71%
Mar 31, 2025
Renaissance Technologies LLC
808.30K
1.41%
-23.61K
-2.84%
Mar 31, 2025
Recanati (Leon Yehuda)
631.14K
1.1%
--
--
Dec 31, 2024
Wells Fargo Advisors
608.59K
1.06%
-22.10K
-3.50%
Mar 31, 2025
Tsur (David)
607.93K
1.06%
--
--
Dec 31, 2024
Millennium Management LLC
448.19K
0.78%
+130.29K
+40.98%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
412.01K
0.72%
+9.32K
+2.31%
May 31, 2025
More Investment House Ltd.
330.35K
0.57%
-168.57K
-33.79%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
ARK Israel Innovative Technology ETF
1.69%
DFA Dimensional International Small Cap Value ETF
0.01%
DFA Dimensional International Small Cap ETF
0.01%
Schwab International Small-Cap Equity ETF
0%
Avantis International Equity ETF
0%
Dimensional International Core Equity Market ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
Vanguard Total World Stock Index Fund
0%
Vanguard ESG International Stock ETF
0%
ARK Israel Innovative Technology ETF
Proportion1.69%
DFA Dimensional International Small Cap Value ETF
Proportion0.01%
DFA Dimensional International Small Cap ETF
Proportion0.01%
Schwab International Small-Cap Equity ETF
Proportion0%
Avantis International Equity ETF
Proportion0%
Dimensional International Core Equity Market ETF
Proportion0%
DFA Dimensional International Core Equity 2 ETF
Proportion0%
Vanguard Total World Stock Index Fund
Proportion0%
Vanguard ESG International Stock ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI